Updates

MPAC - Plans to double sales within five years

May 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

I had already provided an update on MPAC in February following its pre-close statement. The pretax profit amounted to £7.1m, with an increase in EPS of 94% to 25.9p. But full year operating profit of £7.8m was split £2.2m:£5.6m between H1:H2, suggesting H2 operating margin of 9.1%, up from 4.2% in H1 and 4% in FY22. This expansion in margin was facilitated by a favourable mix effect, with the share of higher-margin Service revenue growing to 28% of group sales. The strong momentum has continued and the year ended with a strong closing order book of £72.5m (+8% year on year) including a lot of new customers. This provides coverage of over c.60% of broker Liberum’s current year sales estimate of £120m. Based on this, the broker is e ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Inspecs - Q1 signals the corner is turned

Microlise - Acceleration in performance in H2 vs H1

Mpac (June 2024)

MPAC (April 2024)

Mpac (February 2024)

MPAC (August 2023)

Mpac (April 2023)

Mpac Group - Clean energy opportunity (February 2023)

Mpac (August 2022)

Mpac - Order intake in year >£100m (April 2022)

Mpac Group - Resilient performance for FY21 (February 2022)

MPAC - Lollies driving sales of packaging equipment in US (October 2021)

Mpac (August 2021)

Mpac (May 2021)

Mpac - Trading ahead of forecast (February 2021)

Mpac Group - Enters fast growing craft beer packaging market (October 2020)

Mpac - Noticeable resilience in healthcare sector (August 2020)

Mpac (April 2020)

Mpac - Meeting notes (March 2020)

Mpac - Five profit upgrades in FY19 (February 2020)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X